Skip to main content
. 2020 Feb 4;21:69–74. doi: 10.1016/j.jor.2020.02.004

Table 2.

Back pain and physical function between male patients with Scheuermann's disease and control group Health 2000.

Patients with Scheuermann's disease
Health 2000 controls
Patients with Scheuermann's disease
p-valuesb
n = 22
n = 26

mean (SD) mean (SD) mean difference (95 %CI)a
General health c 6.6 (2.4) 8.0 (1.7) −1.02 (−2.50-0.96) 0.069
The quality of life c 6.9 (2.5) 7.9 (1.7) −0.92 (−2.22-0.39) 0.163
Five-repetition sit-to-stand test (seconds) 15.1 (6.6) 11.7 (2.8) 3.37 (−0.11-6.85) 0.057
Walking time in 6.1 m (seconds) 4.0 (1.8) 3.6 (1.0) 0.53 (−0.43-1.50) 0.269
Number of steps during 6.1 m 8.4 (2.3) 7.4 (1.1) 1.05 (−0.12-2.22) 0.076
Walking speed (m/s) 1.7 (0.5) 1.8 (0.4) −0.10 (−0.40-0.10) 0.485

%
%
OR (95% CI)d

Constant back pain, (%) 41 8 9.41 (1.56–56.97) 0.015
Disability because of back pain during last 5 years, (%) 50 12 5.48 (1.19–25.23) 0.029
Back pain during last 30 days, (%) 68 4 45.00 (4.92–411.32) 0.001
Sciatica, (%) 50 46 1.21 (0.36–4.09) 0.755
Constant sciatica, (%) 14 4 4.76 (0.40–56.89) 0.217
Neck pain during last 30 days, (%) 59 8 27.26 (3.95–188.05) 0.001
Shoulder pain during last 30 days, (%) 55 8 14.13 (2.48–80.55) 0.003
Difficulties carrying 5-kg load at least 100 m, (%) 36 0
Difficulties in walking up one floor without resting, (%) 27 4 9.82 (1.01–95.34) 0.049
Other chronic diseases, (%) 77 46 3.36 (0.89–12.63) 0.073
a

ANCOVA, age-adjusted mean difference and its 95% CI confidence intervals [95% CI] for general health, quality of life and physical function in male patients with Scheuermann's disease (n = 22) compared to male controls (n = 26), adjusted for age.

b

p-values are distributed between patients and controls.

c

Self-reported outcomes measured by visual analogue scale (VAS), 0 to 10, where 0 is the worst and 10 is the best possible.

d

Odds Ratios [OR] and their 95% confidence intervals [95% CI] for back symptoms and activities of daily living in male patients with Scheuermann's disease (n = 22) compared to male controls (n = 26), adjusted for age.